IPSC
Century Therapeutics, Inc.
Next earnings Aug 3, 2026 (before open) · consensus $-0.12 EPS
Last earnings -0.4% on 2026-05-13
$2.30
▲ +0.44%$2.30▲ +292.22%
over 1Y
L $0.46EODHDH $2.94
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.4%
1W+1.8%
1M+5.5%
3M+10.6%
YTD+130.2%
1Y+290.5%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 12 analysts
Buy
Revenue grew 1556.8% YoY; but unprofitable (net margin -8.8%).
Century Therapeutics, Inc. shows $109M in FY2025 revenue (+1556.8% YoY), a -8.8% net margin, and -6.0% ROE.
Sources: SEC EDGAR (CIK 0001850119, latest 10-Q filed 2026-05-13) · EODHD · as of 6/22/2026, 9:48:46 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.